Kazakhstan Advances in Cancer Drug Development
The drug, developed at Nazarbayev University's National Laboratory Astana, targets a specific cancer type and could become the country's first domestically produced oncology treatment.
A domestically developed cancer drug, pioneered by researchers at the National Laboratory Astana (Nazarbayev University), has officially reached the penultimate stage of clinical trials. Preparations are now underway to submit this highly anticipated oncology treatment for official registration by early next year.
This breakthrough represents a monumental achievement for Kazakhstan’s scientific community. Transforming Kazakhstan into a leading academic and scientific hub requires moving beyond theoretical research toward tangible, high-impact solutions that save lives while strengthening the country’s sovereign biotechnology capabilities.
Recent international and English-language coverage highlighting this achievement is presented below:
* https://tiek.kz/en/archives/10633
* https://qazinform.com/news/kazakhstan-to-register-its-first-homegrown-cancer-drug-by-year-end-861ab9
* https://kz.kursiv.media/en/2026-08-19/engk-nknk-kazakhstans-cancer-drug-could-be-registered-in-2027/
* https://en.tengrinews.kz/health/cancer-drug-being-prepared-for-registration-in-kazakhstan-272964/
EUReflect News
Site Administrator
Follow EUReflect
See more of our reporting on Google
Mark EUReflect as a preferred source and our stories are ranked higher for you in Top Stories, Discover and Google News — and carry a “preferred” badge when they are cited in AI results.
Add EUReflect as a preferred source
